LIPOCINE INC. Retained Earnings
LIPOCINE INC. (LPCN) had Retained Earnings of -$215.69 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$215.69M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$213.07M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$209.40M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$207.03M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$215.69M 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$213.07M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$209.40M 10-Q · filed 2026-08-04 |
| 2025-09-30 | -$207.03M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$203.84M 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$201.63M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$199.77M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$201.55M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$199.33M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$196.26M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$199.78M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$197.49M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$190.84M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$187.30M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$183.43M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$181.20M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$178.79M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$176.15M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$172.67M 10-K · filed 2023-03-10 |
| 2021-09-30 | -$185.29M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$182.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$175.40M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$172.03M 10-K · filed 2022-03-09 |
| 2020-09-30 | -$167.52M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$163.21M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$156.84M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$151.07M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$147.78M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$144.71M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$141.28M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$138.06M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$134.83M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$132.38M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$129.12M 10-Q · filed 2018-05-07 |
| 2017-12-31 | -$126.40M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$121.07M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$116.37M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$110.28M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$105.42M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$102.45M 10-Q · filed 2016-11-08 |
| 2016-06-30 | -$99.22M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$93.45M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$86.45M 10-K · filed 2017-03-06 |
| 2015-09-30 | -$81.81M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$75.44M 10-Q · filed 2015-08-11 |
| 2015-03-31 | -$71.19M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$68.24M 10-K · filed 2016-03-10 |
| 2014-09-30 | -$64.20M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$60.10M 10-Q · filed 2014-08-13 |
| 2014-03-31 | -$53.13M 10-Q · filed 2014-05-13 |
| 2013-12-31 | -$47.86M 10-K · filed 2015-03-11 |
| 2013-09-30 | -$43.47M 10-Q · filed 2013-11-13 |
| 2012-12-31 | -$37.27M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |